首页 › 基金 › Nextech Invest Ltd. › GLUE
Nextech Invest Ltd. 对 GLUE 的持仓历史
MONTE ROSA THERAPEUTICS INC · 医疗保健
Nextech Invest Ltd. 在 Q3 2026 的 13F 申报中披露持有 GLUE(MONTE ROSA THERAPEUTICS INC)761,153 股,市值约 US$9.1M,约占其申报组合的 0.41%,在其申报持仓中市值排名第 14 位。 Nextech Invest Ltd. 最近 4 个申报季度中有 4 个季度披露了 GLUE 持仓,最早可追溯至 Q4 2025。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Nextech Invest Ltd. 对 GLUE 的持仓演变
Nextech Invest Ltd. 于 Q4 2025 首次披露 GLUE 持仓:279,237 股(约 US$4.4M)。 该持仓在 Q2 2026 达到峰值 761,153 股,市值约 US$18.4M。 在 4 次申报中,Nextech Invest Ltd. 2 次增持、0 次减持、1 次保持不变。 最近一期申报(Q3 2026)显示持股 761,153 股、市值约 US$9.1M。 持仓曾出现大幅变动:Q2 2026 增持约 150% (随后一个季度股价下跌 51%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q4 2025 | 279.24K | $4.38M | 新进 |
| Q1 2026 | 304.24K | $5.00M | 增持 |
| Q2 2026 | 761.15K | $18.42M | 增持 |
| Q3 2026 | 761.15K | $9.08M | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 GLUE 与 13F 数据
GLUE(MONTE ROSA THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 48 只申报持有 GLUE,申报仓位最大的包括:Vestal Point Capital, LP (US$85.1M), NEA Management Company, LLC (US$79.8M), BAKER BROS. ADVISORS LP (US$51.8M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 GLUE 的基金
- Vestal Point Capital, LP 7.13M 股 · $85.06M · Q3 2026
- NEA Management Company, LLC 6.69M 股 · $79.84M · Q3 2026
- BAKER BROS. ADVISORS LP 4.35M 股 · $51.84M · Q3 2026
- BVF INC/IL 4.28M 股 · $51.02M · Q3 2026
- TCG Crossover Management, LLC 3.78M 股 · $45.11M · Q3 2026
- Versant Venture Management, LLC 3.18M 股 · $37.95M · Q3 2026
- MONTANOVA CAPITAL, LLC 2.92M 股 · $34.79M · Q3 2026
- BRAIDWELL LP 2.53M 股 · $30.14M · Q3 2026
- Aisling Capital Management LP 1.56M 股 · $18.56M · Q3 2026
- Opaleye Management Inc. 745.00K 股 · $18.03M · Q2 2026
- MPM BioImpact LLC 1.13M 股 · $13.42M · Q3 2026
- ADAR1 Capital Management, LLC 1.01M 股 · $12.02M · Q3 2026
更多关于 Nextech Invest Ltd.
常见问题
How long has Nextech Invest Ltd. held GLUE?
Nextech Invest Ltd. has disclosed GLUE holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is Nextech Invest Ltd.'s current position in GLUE?
As of Q3 2026, Nextech Invest Ltd. holds 761.15K shares of GLUE (MONTE ROSA THERAPEUTICS INC), valued at $9.08M, representing 0.41% of its reported portfolio and ranking #14.
Has Nextech Invest Ltd. been buying or selling GLUE?
In the latest 13F filing (Q3 2026), Nextech Invest Ltd. held unchanged its position in GLUE. The position peaked in Q2 2026 at 761.15K shares.
Which other funds hold GLUE?
Other major institutional holders of GLUE include Vestal Point Capital, LP, NEA Management Company, LLC, BAKER BROS. ADVISORS LP, among 48 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.